{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:43:06Z","timestamp":1778132586282,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R15NS108815,R01AI147731,"],"award-info":[{"award-number":["R15NS108815,R01AI147731,"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R15NS108815,R01AI147731,"],"award-info":[{"award-number":["R15NS108815,R01AI147731,"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R15NS108815,R01AI147731,"],"award-info":[{"award-number":["R15NS108815,R01AI147731,"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R15NS108815,R01AI147731,"],"award-info":[{"award-number":["R15NS108815,R01AI147731,"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014108","name":"University of Texas Rio Grande Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The United Nations projects that one in every six people will be over the age of 65 by the year 2050. With a rapidly aging population, the risk of Alzheimer's disease (AD) becomes a major concern. AD is a multifactorial disease that involves neurodegeneration in the brain with mild dementia and deficits in memory and other cognitive domains. Additionally, it has been established that individuals with Human Immunodeficiency Virus-1 (HIV-1) experience a 5 to 10-year accelerated aging and an increased risk of developing HIV-associated neurocognitive disorders (HAND). Despite a significant amount of clinical evidence pointing towards a potential overlap between neuropathogenic processes in HAND and AD, the underlying epigenetic link between these two diseases is mostly unknown. This study is focused on identifying differentially expressed genes observed in both AD and HAND using linear regression models and a more robust significance analysis of microarray. The results established that the dysregulated type 1 and 2 interferon pathways observed in both AD and HAND contribute to the similar pathologies of these diseases within the brain. The current study identifies the important roles of interferon pathways in AD and HAND, a relationship that may be useful for earlier detection in the future.<\/jats:p>","DOI":"10.1038\/s41598-022-27276-7","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T11:02:49Z","timestamp":1677322969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders"],"prefix":"10.1038","volume":"13","author":[{"given":"Armando","family":"Garces","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"De La Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylie-Anna","family":"Vallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerel Adam","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansapani","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"issue":"9","key":"27276_CR1","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/cells8090968","volume":"8","author":"S Kodidela","year":"2019","unstructured":"Kodidela, S. et al. Extracellular vesicles: A possible link between HIV and alzheimer\u2019s disease-like pathology in HIV subjects?. Cells 8(9), 968 (2019).","journal-title":"Cells"},{"key":"27276_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2019.07.006","volume":"82","author":"B Milanini","year":"2019","unstructured":"Milanini, B. et al. Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared to early alzheimer\u2019s disease. Neurobiol. Aging 82, 69\u201376 (2019).","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"27276_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s13365-018-0695-4","volume":"25","author":"L Pulliam","year":"2019","unstructured":"Pulliam, L., Sun, B., Mustapic, M., Chawla, S. & Kapogiannis, D. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and alzheimer\u2019s disease. J. Neurovirol. 25(5), 702\u2013709 (2019).","journal-title":"J. Neurovirol."},{"issue":"1","key":"27276_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12879-017-2246-7","volume":"17","author":"I Solomon","year":"2017","unstructured":"Solomon, I. et al. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect. Dis. 17(1), 151\u2013151 (2017).","journal-title":"BMC Infect. Dis."},{"key":"27276_CR5","doi-asserted-by":"publisher","first-page":"146389","DOI":"10.1016\/j.brainres.2019.146389","volume":"1722","author":"N Khan","year":"2019","unstructured":"Khan, N., Haughey, N., Nath, A. & Geiger, J. Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and alzheimer\u2019s disease. Brain Res. 1722, 146389\u2013146389 (2019).","journal-title":"Brain Res."},{"issue":"5","key":"27276_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13365-018-0702-9","volume":"25","author":"L Rubin","year":"2019","unstructured":"Rubin, L., Sundermann, E. & Moore, D. The current understanding of the overlap between characteristics of HIV-associated neurocognitive disorders and alzheimer\u2019s disease. J. Neurovirol. 25(5), 661\u2013672 (2019).","journal-title":"J. Neurovirol."},{"key":"27276_CR7","doi-asserted-by":"crossref","unstructured":"2020 Alzheimer's disease facts and figures. Alzheimer's Dementia, 16(3), 391\u2013460 (2020).","DOI":"10.1002\/alz.12068"},{"key":"27276_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2147\/CIA.S11718","volume":"5","author":"A Isik","year":"2010","unstructured":"Isik, A. Late-onset alzheimer\u2019s disease in older people. Clin. Interv. Aging 5, 307\u2013311 (2010).","journal-title":"Clin. Interv. Aging"},{"issue":"200","key":"27276_CR9","first-page":"e13","volume":"41","author":"P Ridge","year":"2015","unstructured":"Ridge, P. et al. Assessment of the genetic variance of late-onset Alzheimer\u2019s disease. Neurobiol. Aging 41(200), e13-200.e20 (2015).","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"27276_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou, M., Minguill\u00f3n, C., Gramunt, N. & Molinuevo, J. Alzheimer\u2019s disease prevention: From risk factors to early intervention. Alzheimer\u2019s Res. Ther. 9(1), 71\u201371 (2017).","journal-title":"Alzheimer's Res. Ther."},{"issue":"3","key":"27276_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1128\/CMR.00006-07","volume":"20","author":"S Hariri","year":"2007","unstructured":"Hariri, S. & McKenna, M. T. Epidemiology of human immunodeficiency virus in the United States. Clin. Microbiol. Rev. 20(3), 478\u2013488 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"27276_CR12","unstructured":"UNAIDS.(2022). https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Date (Accessed: 11\/15\/2022)"},{"issue":"3","key":"27276_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/CPJ.0000000000000117","volume":"5","author":"J Rumbaugh","year":"2015","unstructured":"Rumbaugh, J. & Tyor, W. HIV-associated neurocognitive disorders: Five new things. Neurol. Clin. Pract. 5(3), 224\u2013231 (2015).","journal-title":"Neurol. Clin. Pract."},{"issue":"6","key":"27276_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/01.aids.0000218552.69834.00","volume":"20","author":"Moore, D. J., Masliah, E., Rippeth, J. D., Gonzalez, R., Carey, C. L., Cherner, M., Ellis, R. J., Achim, C. L., Marcotte, T. D., Heaton, R. K., Grant, I. & HNRC Group","year":"2006","unstructured":"Moore, D. J., Masliah, E., Rippeth, J. D., Gonzalez, R., Carey, C. L., Cherner, M., Ellis, R. J., Achim, C. L., Marcotte, T. D., Heaton, R. K., Grant, I. & HNRC Group. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20(6), 879\u2013887 (2006).","journal-title":"AIDS"},{"issue":"1","key":"27276_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jneuroim.2005.09.009","volume":"170","author":"I Everall","year":"2005","unstructured":"Everall, I. et al. Methamphetamine stimulates interferon-inducible genes in HIV infected brain. J. Neuroimmunol. 170(1), 158\u2013171 (2005).","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"27276_CR16","doi-asserted-by":"publisher","first-page":"e46178","DOI":"10.1371\/journal.pone.0046178","volume":"7","author":"B Gelman","year":"2012","unstructured":"Gelman, B. et al. The national NeuroAIDS tissue consortium brain gene array: Two types of HIV-associated neurocognitive impairment. PLoS ONE 7(9), e46178\u2013e46178 (2012).","journal-title":"PLoS ONE"},{"issue":"1","key":"27276_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jneuroim.2004.08.026","volume":"157","author":"E Masliah","year":"2004","unstructured":"Masliah, E. et al. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J. Neuroimmunol. 157(1), 163\u2013175 (2004).","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"27276_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13365-016-0499-3","volume":"23","author":"Y Garcia-Mesa","year":"2017","unstructured":"Garcia-Mesa, Y. et al. Immortalization of primary microglia: A new platform to study HIV regulation in the central nervous system. J. Neurovirol. 23(1), 47\u201366 (2017).","journal-title":"J. Neurovirol."},{"issue":"5","key":"27276_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13365-019-00735-0","volume":"25","author":"J Rosenthal","year":"2019","unstructured":"Rosenthal, J. & Tyor, W. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders. J. Neurovirol. 25(5), 673\u2013685 (2019).","journal-title":"J. Neurovirol."},{"issue":"1","key":"27276_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","volume":"5","author":"H Hippius","year":"2003","unstructured":"Hippius, H. & Neund\u00f6rfer, G. The discovery of alzheimer\u2019s disease. Dialogues Clin. Neurosci. 5(1), 101\u2013108 (2003).","journal-title":"Dialogues Clin. Neurosci."},{"issue":"5","key":"27276_CR21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s13365-019-00732-3","volume":"25","author":"T Fulop","year":"2019","unstructured":"Fulop, T. et al. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and alzheimer\u2019s disease?. J. Neurovirol. 25(5), 634\u2013647 (2019).","journal-title":"J. Neurovirol."},{"issue":"4","key":"27276_CR22","first-page":"e739","volume":"7","author":"G Howdle","year":"2020","unstructured":"Howdle, G. et al. Brain amyloid in virally suppressed HIV-associated neurocognitive disorder. Neurol.: Neuroimmunol. Neuroinflammation 7(4), e739\u2013e739 (2020).","journal-title":"Neurol.: Neuroimmunol. Neuroinflammation"},{"issue":"7","key":"27276_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/QAD.0000000000002506","volume":"34","author":"JA Fields","year":"2020","unstructured":"Fields, J. A., Swinton, M. K., Soontornniyomkij, B., Carson, A. & Achim, C. L. Beta-amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS 34(7), 1001\u20131007 (2020).","journal-title":"AIDS"},{"issue":"6","key":"27276_CR24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/jnc.14582","volume":"147","author":"JA Fields","year":"2018","unstructured":"Fields, J. A. et al. Alterations in brain TREM2 and amyloid-\u03b2 levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J. Neurochem. 147(6), 784\u2013802 (2018).","journal-title":"J. Neurochem."},{"key":"27276_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough, E. & Barrett, T. The gene expression omnibus database. Methods Mol Biol 1418, 93\u2013110 (2016).","journal-title":"Methods Mol Biol"},{"issue":"1","key":"27276_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jcmm.13852","volume":"23","author":"L Sun","year":"2019","unstructured":"Sun, L., Yang, S., Sun, H., Li, W. & Duan, S. Molecular differences in alzheimer\u2019s disease between male and female patients determined by integrative network analysis. J. Cell Mol. Med. 23(1), 47\u201358 (2019).","journal-title":"J. Cell Mol. Med."},{"issue":"468","key":"27276_CR27","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1198\/016214504000000683","volume":"99","author":"Z Wu","year":"2004","unstructured":"Wu, Z., Irizarry, R., Gentleman, R., Martinez-Murillo, F. & Spencer, F. A model-based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 99(468), 909\u2013917 (2004).","journal-title":"J. Am. Stat. Assoc."},{"key":"27276_CR28","unstructured":"Z.J, W. and R., I. (2021). Description of Gcrma Package Manual. https:\/\/www.bioconductor.org\/packages\/devel\/bioc\/vignettes\/gcrma\/inst\/doc\/gcrma2.0.pdf (Accessed on 02\/11\/2022)"},{"key":"27276_CR29","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","author":"GK Smyth","year":"2004","unstructured":"Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. https:\/\/doi.org\/10.2202\/1544-6115.1027 (2004).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"issue":"9","key":"27276_CR30","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci\u2013PNAS 98(9), 5116\u20135121 (2001).","journal-title":"Proc. Natl. Acad. Sci\u2013PNAS"},{"key":"27276_CR31","unstructured":"Chu, G., Narasimham, B., Tibshirani, R. and Tusher, V. G. (2005). SAM \"Significance Analysis of Microarrays\" Users Guide and Technical Document. Policy. https:\/\/web.stanford.edu\/~wanjen\/Chu%20Lab\/Papers\/sam.pdf (Accessed on 02\/11\/2022)."},{"issue":"1","key":"27276_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2008","unstructured":"Huang, D. W., Lempicki, R. A. & Sherman, B. T. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4(1), 44\u201357 (2008).","journal-title":"Nat. Protoc."},{"issue":"18","key":"27276_CR33","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1523\/JNEUROSCI.1280-17.2018","volume":"38","author":"AL Stern","year":"2018","unstructured":"Stern, A. L. et al. BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism. J. Neurosci.: Off. J. Soc. Neurosci. 38(18), 4288\u20134300 (2018).","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"15","key":"27276_CR34","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1128\/JVI.00421-07","volume":"81","author":"A Meier","year":"2007","unstructured":"Meier, A. et al. MyD88-dependent immune activation mediated by human immunodeficiency virus Type 1-encoded toll-like receptor ligands. J. Virol. 81(15), 8180\u20138191 (2007).","journal-title":"J. Virol."},{"issue":"5","key":"27276_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of Type-I- and Type-II-interferon-mediated signaling. Nat. Rev. Immunol. 5(5), 375\u2013386 (2005).","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"27276_CR36","doi-asserted-by":"publisher","first-page":"e76581","DOI":"10.1371\/journal.pone.0076581","volume":"8","author":"L Zhao","year":"2013","unstructured":"Zhao, L., Huang, Y. & Zheng, J. STAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophages. PLoS ONE 8(9), e76581 (2013).","journal-title":"PLoS ONE"},{"issue":"5","key":"27276_CR37","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.neurobiolaging.2013.10.089","volume":"35","author":"J Taylor","year":"2014","unstructured":"Taylor, J. et al. Type-1 interferon signaling mediates neuro-inflammatory events in models of alzheimer\u2019s disease. Neurobiol. Aging 35(5), 1012\u20131023 (2014).","journal-title":"Neurobiol. Aging"},{"key":"27276_CR38","doi-asserted-by":"crossref","unstructured":"OseiKuffour, E., K\u00f6nig, R., H\u00e4ussinger, D., Schulz, W., & M\u00fcnk, C. ISG15 deficiency enhances HIV-1 infection by accumulating misfolded p53. mBio, 10(4), e01342-19 (2019).","DOI":"10.1128\/mBio.01342-19"},{"issue":"2","key":"27276_CR39","doi-asserted-by":"publisher","first-page":"e01155","DOI":"10.1128\/JVI.01155-20","volume":"95","author":"C G\u00f3mez","year":"2020","unstructured":"G\u00f3mez, C. et al. Enhancement of HIV-1 env-specific CD8 T cell responses using interferon-stimulated gene 15 as an immune adjuvant. J. Virol. 95(2), e01155 (2020).","journal-title":"J. Virol."},{"issue":"3","key":"27276_CR40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/npp.2013.263","volume":"39","author":"W Hsu","year":"2014","unstructured":"Hsu, W., Ma, Y., Hsieh, D., Liu, Y. & Lee, E. STAT1 negatively regulates spatial memory formation and mediates the memory-mpairing effect of A\u03b2. Neuropsychopharmacology 39(3), 746\u2013758 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"27276_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","volume":"517","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Human Intracellular ISG15 Prevents Interferon-\u03b1\/\u03b2 Over-amplification and Auto-inflammation. Nature 517, 89\u201393 (2015).","journal-title":"Nature"},{"issue":"2","key":"27276_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11357-019-00071-5","volume":"41","author":"A Nazarian","year":"2019","unstructured":"Nazarian, A., Arbeev, K., Yashkin, A. & Kulminski, A. Genetic heterogeneity of alzheimer\u2019s disease in subjects with and without hypertension. GeroScience 41(2), 137\u2013154 (2019).","journal-title":"GeroScience"},{"issue":"7","key":"27276_CR43","first-page":"P242","volume":"12","author":"C Dansokho","year":"2016","unstructured":"Dansokho, C. et al. Regulatory T cells delay disease progression in alzheimers like pathology. Alzheimers Dement. 12(7), P242\u2013P242 (2016).","journal-title":"Alzheimers Dement."},{"issue":"3","key":"27276_CR44","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/ijms21031126","volume":"21","author":"M Romagnoli","year":"2020","unstructured":"Romagnoli, M., Porcellini, E., Carbone, I., Veerhuis, R. & Licastro, F. Impaired innate immunity mechanisms in the brain of alzheimer\u2019s disease. Int. J. Mol. Sci. 21(3), 1126 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"27276_CR45","doi-asserted-by":"publisher","first-page":"16209","DOI":"10.1073\/pnas.252454799","volume":"99","author":"J Wang","year":"2002","unstructured":"Wang, J., Schreiber, R. D. & Campbell, I. L. STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-\u03b1 in the central nervous system. Proc. Natl. Acad. Sci.\u2013PNAS 99(25), 16209\u201316214 (2002).","journal-title":"Proc. Natl. Acad. Sci.\u2013PNAS"},{"issue":"4","key":"27276_CR46","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"E Roy","year":"2020","unstructured":"Roy, E. et al. Type I interferon response drives neuroinflammation and synapse loss in alzheimer disease. J. Clin. Investig. 130(4), 1912\u20131930 (2020).","journal-title":"J. Clin. Investig."},{"key":"27276_CR47","doi-asserted-by":"crossref","unstructured":"Hwang, M., & Bergmann, C. C. Neuronal ablation of Alpha\/Beta interferon (IFN-\u03b1\/\u03b2) signaling exacerbates central nervous system viral dissemination and impairs IFN-\u03b3 responsiveness in microglia\/macrophages. J. Virol., 94(20) (2020).","DOI":"10.1128\/JVI.00422-20"},{"issue":"11","key":"27276_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/jir.2013.0085","volume":"34","author":"M Belkhelfa","year":"2014","unstructured":"Belkhelfa, M. et al. IFN-\u03b3 and TNF-\u03b1 are involved during alzheimer disease progression and correlate with nitric oxide production: a study in algerian patients. J. Interferon Cytokine Res. 34(11), 839\u2013847 (2014).","journal-title":"J. Interferon Cytokine Res."},{"key":"27276_CR49","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/1742-2094-9-7","volume":"9","author":"E Lee","year":"2012","unstructured":"Lee, E., Chanamara, S., Pleasure, D. & Soulika, A. M. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J. Neuroinflammation 9, 510 (2012).","journal-title":"J. Neuroinflammation"},{"key":"27276_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbi.2020.05.070","volume":"89","author":"M Unger","year":"2020","unstructured":"Unger, M. et al. CD8+ T-cells Infiltrate alzheimer\u2019s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice. Brain Behav. Immun. 89, 67\u201386 (2020).","journal-title":"Brain Behav. Immun."},{"key":"27276_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12974-017-0925-3","volume":"14","author":"R Roshan","year":"2017","unstructured":"Roshan, R. et al. MicroRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells. J. Neuroinflammation 14, 155 (2017).","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"27276_CR52","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41380-018-0286-z","volume":"26","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. \u03b4-secretase-cleaved Tau stimulates A\u03b2 production via upregulating STAT1-BACE1 signaling in alzheimer\u2019s disease. Mol. Psychiatry 26(2), 586\u2013603 (2021).","journal-title":"Mol. Psychiatry"},{"key":"27276_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neures.2015.09.002","volume":"105","author":"T Imaizumi","year":"2016","unstructured":"Imaizumi, T. et al. Interferon-stimulated Gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3\/IFN-\u03b2\/STAT1 axis in U373MG human astrocytoma cells. Neurosci. Res. 105, 35\u201341 (2016).","journal-title":"Neurosci. Res."},{"key":"27276_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","volume":"6","author":"V Pidugu","year":"2019","unstructured":"Pidugu, V., Pidugu, H., Wu, M., Liu, C. & Lee, T. Emerging functions of human IFIT proteins in cancer. Front. Mol. Biosci. 6, 148\u2013148 (2019).","journal-title":"Front. Mol. Biosci."},{"issue":"17","key":"27276_CR55","doi-asserted-by":"publisher","first-page":"14703","DOI":"10.1074\/jbc.M111527200","volume":"277","author":"O Malakhova","year":"2002","unstructured":"Malakhova, O., Malakhova, M., Hetherington, C. & Zhang, D.-E. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277(17), 14703\u201314711 (2002).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"27276_CR56","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11481-013-9511-3","volume":"8","author":"J Fields","year":"2013","unstructured":"Fields, J. et al. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 8(5), 1197\u20131209 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"27276_CR57","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk, A. et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and alzheimer\u2019s disease. Neuron 100(6), 1337-1353.e5 (2018).","journal-title":"Neuron"},{"key":"27276_CR58","doi-asserted-by":"crossref","unstructured":"Ayton, J. Acute Phase Markers in CSF Reveal Inflammatory Changes in Alzheimer's Disease that Intersect with Pathology, APOE \u03b54, Sex, and Age. Progress in Neurobiology, 101904\u2013101904 (2020).","DOI":"10.1016\/j.pneurobio.2020.101904"},{"issue":"1","key":"27276_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12974-017-0794-9","volume":"14","author":"J Nitkiewicz","year":"2017","unstructured":"Nitkiewicz, J. et al. HIV induces expression of complement component C3 in astrocytes by NF-\u03baB-dependent activation of interleukin-6 synthesis. J. Neuroinflammation 14(1), 23 (2017).","journal-title":"J. Neuroinflammation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27276-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T11:07:43Z","timestamp":1677323263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27276-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["27276"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-27276-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3276"}}